StonvexLoading…
StonvexCore line items from WST's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $3.07B | $2.89B | $2.95B | $2.89B |
Operating Income | $584.90M | $569.90M | $676.00M | $734.00M |
Net Income | $493.70M | $492.70M | $593.40M | $585.90M |
EPS (Diluted) | $6.79 | $6.69 | $7.88 | $7.73 |
Total Assets | $4.27B | $3.64B | $3.83B | $3.62B |
Total Liabilities | $1.09B | $961.10M | $948.50M | $931.90M |
Cash & Equivalents | $791.30M | $484.60M | $853.90M | $894.30M |
Free Cash Flow OCF − CapEx | $468.90M | $276.40M | $414.50M | $439.40M |
Shares Outstanding | 72.00M | 72.30M | 73.50M | 74.10M |